CSF2 and neoplasm: OX40 agonists have also been combined with DC vaccines pulsed with soluble protein or apoptotic tumor cells [24], and with whole tumor cell vaccines secreting granulocyte-macrophage colony-stimulating factor (GM-CSF) [13, 25].